CD79A and COVID-19: Therefore, we subtracted 0.05 from the sensitivity and specificity values to obtain an estimated positive LR of 159.7, which means that a SARS-CoV-2-positive individual has approximately 160-fold higher probability of having COVID-19 when tested with the IBMP ELISA IgA/IgM/IgG COVID-19 kit.